, a bio/informatics shared resource is still "open for business" - Visit the CDS website

  1. Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Barnard JA, Beauchamp RD, Russell WE, Dubois RN, Coffey RJ (1995) Gastroenterology 108(2): 564-80
    › Primary publication · 7835600 (PubMed)
  2. Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis. Witty JP, Lempka T, Coffey RJ, Matrisian LM (1995) Cancer Res 55(7): 1401-6
    › Primary publication · 7882342 (PubMed)
  3. Basic actions of transforming growth factor-alpha and related peptides. Coffey RJ, Gangarosa LM, Damstrup L, Dempsey PJ (1995) Eur J Gastroenterol Hepatol 7(10): 923-7
    › Primary publication · 8590135 (PubMed)
  4. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN (1994) Gastroenterology 107(4): 1183-8
    › Primary publication · 7926468 (PubMed)
  5. Basolateral targeting and efficient consumption of transforming growth factor-alpha when expressed in Madin-Darby canine kidney cells. Dempsey PJ, Coffey RJ (1994) J Biol Chem 269(24): 16878-89
    › Primary publication · 8207010 (PubMed)
  6. Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family. Barnard JA, Graves-Deal R, Pittelkow MR, DuBois R, Cook P, Ramsey GW, Bishop PR, Damstrup L, Coffey RJ (1994) J Biol Chem 269(36): 22817-22
    › Primary publication · 8077234 (PubMed)
  7. Acceleration of mammary neoplasia in transforming growth factor alpha transgenic mice by 7,12-dimethylbenzanthracene. Coffey RJ, Meise KS, Matsui Y, Hogan BL, Dempsey PJ, Halter SA (1994) Cancer Res 54(7): 1678-83
    › Primary publication · 8137281 (PubMed)
  8. Transforming growth factor-alpha (TGF alpha) concentrations increase in regenerating rat liver: evidence for a delayed accumulation of mature TGF alpha. Russell WE, Dempsey PJ, Sitaric S, Peck AJ, Coffey RJ (1993) Endocrinology 133(4): 1731-8
    › Primary publication · 8404616 (PubMed)
  9. Chronic administration of transforming growth factor-beta suppresses erythropoietin-dependent erythropoiesis and induces tumour necrosis factor in vivo. Chuncharunee S, Carter CD, Studtmann KE, Caro J, Coffey RJ, Dessypris EN (1993) Br J Haematol 84(3): 374-80
    › Primary publication · 8217788 (PubMed)
  10. Transforming growth factors and related peptides in gastrointestinal neoplasia. Coffey RJ, McCutchen CM, Graves-Deal R, Polk WH (1992) J Cell Biochem Suppl : 111-8
    › Primary publication · 1335097 (PubMed)